Catalyst Wire Dossier Catalyst Wire Dossier

Tiotropium 18 μg inhalation powder, hard capsule

tiotropium
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tiotropium 18 μg inhalation powder, hard capsule, covering 2024-01-31 to 2024-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

See pricing